ADC Therapeutics (NYSE: ADCT) Exceeds Q3 2026 Earnings Expectations with ZYNLONTA Growth
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameArt Design & Communication JSC
-
IndustryIT Services and Computer Programming
-
М/S&P/F
*** /*** /***










